{ "tag": [ "compiled" ], "id": "ocds-r6ebe6-0000535103-2018-05-15T00:00:00Z", "date": "2018-05-15T00:00:00Z", "ocid": "ocds-r6ebe6-0000535103", "initiationType": "tender", "parties": [ { "id": "org-9", "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")", "identifier": { "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")" }, "address": { "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent", "locality": "Edinburgh", "region": "UKM", "postalCode": "EH12 9EB" }, "contactPoint": { "name": "Andrew Fitzpatrick", "email": "andrew.fitzpatrick1@nhs.net", "telephone": "+44 1698794540", "url": "http://genss.nss.scot.nhs.uk/portal/page?_pageid=515,1&_dad=portal&_schema=PORTAL" }, "roles": [ "buyer", "centralPurchasingBody", "reviewBody" ], "details": { "classifications": [ { "id": "Body governed by public law", "scheme": "TED_CA_TYPE" }, { "id": "07", "description": "Health", "scheme": "COFOG" }, { "id": "Regional or local authority", "scheme": "TED_CA_TYPE" } ], "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/" } }, { "id": "org-29", "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")", "identifier": { "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")" }, "address": { "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent", "locality": "Edinburgh", "region": "UKM", "postalCode": "EH12 9EB" }, "contactPoint": { "name": "Stuart Gillespie", "email": "stuart.gillespie@nhs.net", "telephone": "+44 1698794410", "url": "http://" }, "roles": [ "buyer", "centralPurchasingBody", "reviewBody" ], "details": { "classifications": [ { "id": "Body governed by public law", "scheme": "TED_CA_TYPE" }, { "id": "07", "description": "Health", "scheme": "COFOG" }, { "id": "Regional or local authority", "scheme": "TED_CA_TYPE" } ], "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/" } } ], "buyer": { "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")", "id": "org-29" }, "tender": { "id": "NP47818", "title": "Glatiramer Acetate Injection", "description": "Framework Agreement for the supply of Glatiramer Acetate Injection in 20mg and 40mg presentations to Participating Authorities across NHS Scotland. Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioned Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority.", "status": "complete", "items": [ { "id": "1", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" }, { "id": "33661000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "1" }, { "id": "2", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" }, { "id": "33661000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "2" } ], "value": { "amount": 14800000, "currency": "GBP" }, "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "mainProcurementCategory": "goods", "submissionMethod": [ "electronicSubmission" ], "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/esop/pts-host/public/pts/web/login.html", "tenderPeriod": { "endDate": "2018-04-16T12:00:00Z" }, "awardPeriod": { "startDate": "2018-04-16T12:00:00Z" }, "documents": [ { "id": "MAR313682", "documentType": "contractNotice", "title": "Glatiramer Acetate Injection", "description": "Framework Agreement for the supply of Glatiramer Acetate Injection in 20mg and 40mg presentations to Participating Authorities across NHS Scotland. Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioned Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority.", "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR313682", "format": "text/html" }, { "id": "MAY319353", "documentType": "awardNotice", "title": "Glatiramer Acetate Injection", "description": "Framework Agreement for the supply of Glatiramer Acetate Injection in 20mg and 40mg presentations to Participating Authorities across NHS Scotland. Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioned Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority.", "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY319353", "format": "text/html" } ], "lots": [ { "id": "1", "title": "Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service.", "description": "This Lot is for the supply of 20mg and 40mg Glatiramer Acetate Injection direct to hospitals or direct to patients in their own home, or other designated address, via a manufacturer commissioned Home Delivery Service. The Authority intends awarding this Lot as an unranked multi-supplier framework to a maximum of three (3) Framework Participants.", "status": "complete", "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 1080 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the Framework Agreement by further periods of up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s)." } }, { "id": "2", "title": "Glatiramer Acetate Injection excluding a manufacturer commissioned Home Delivery Service", "description": "This Lot is for the supply of 20mg and 40mg glatiramer acetate injection direct to hospitals or nominated Home Delivery supplier(s) as directed by Participating Authorities and/or the Authority. The Authority intends awarding this Lot as an unranked multi-supplier framework to a maximum of three (3) Framework Participants.", "status": "complete", "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 1080 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the Framework Agreement by further periods of up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s)." } } ], "lotDetails": { "maximumLotsBidPerSupplier": 2147483647 }, "bidOpening": { "date": "2018-04-16T12:00:00Z" }, "coveredBy": [ "GPA" ], "selectionCriteria": { "criteria": [ { "type": "suitability", "description": "Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015." }, { "type": "technical", "description": "Lot 1 and Lot 2: (a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. Lot 1 only: (c) All of the goods supplied under the framework agreement must be stored in and distributed from a site holding an MHRA Wholesaler Dealers Authorisation which covers POM medicines. (d) All of the dispensed Goods supplied under the framework agreement will be dispensed in a pharmacy which at the time of dispensing is registered with the General Pharmaceutical Council. (e) All of the Pharmacist and Pharmacy Technician staff used to service this framework agreement will be registered with the General Pharmaceutical Council. (f) The successful Framework Participant and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (g) All of the direct patient contact will be undertaken by staff, including all sub-contractors and couriers that, at the point of service provision, have Protecting Vulnerable Groups Scheme clearance in accordance with the prevailing regulations.", "minimum": "Lot 1 and Lot 2: (a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. Lot 1 only: (c) Confirmation of the storage and distribution site(s)' MHRA Wholesaler Dealers Authorisation registration certificate, together with, in the event that the economic operator would sub-contract the storage and distribution of the medicines to any third party holder of such a certificate, a \"To Whom It May Concern\" letter from the certificate holder confirming that the certificate holder is (or intends to be) party to a contract with the economic operator in terms of which the certificate holder may be required by the economic operator to store and distribute all the medicines which NHS Scotland may require to be supplied in terms of the framework agreement. (d) Confirmation of the dispensing site(s)' General Pharmaceutical Council registration certificate, together with, in the event that the economic operator would sub-contract the dispensing of the medicines to any third party holder of such a certificate, a \"To Whom It May Concern\" letter from the certificate holder confirming that the certificate holder is (or intends to be) party to a contract with the economic operator in terms of which the certificate holder may be required by the economic operator to dispense all medicines which NHS Scotland may require to be dispensed in terms of the framework agreement. (e) Confirmation of the Work Instructions and a description of the processes that would be in place to ensure all Pharmacists and Pharmacy Technicians employed to service this Framework Agreement were registered with the General Pharmaceutical Council. (f) Confirmation of the existence of a valid certification of BS EN ISO 9001 or equivalent. (g) Confirmation of Work Instructions and a description of the processes that would be in place to ensure all staff with direct patient contact had Protecting Vulnerable Groups Scheme clearance at the time of service provision." } ] }, "submissionTerms": { "languages": [ "en" ], "bidValidityPeriod": { "durationInDays": 90 } }, "techniques": { "hasFrameworkAgreement": true, "frameworkAgreement": { "maximumParticipants": 3 } }, "classification": { "id": "33600000", "scheme": "CPV" }, "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.", "hasRecurrence": false }, "language": "EN", "description": "The estimated values referred to in Sections II.1.7 and all Lots cover the thirty six (36) months contract duration and the twelve (12) month extension period of the framework agreement. (SC Ref:542780)", "links": [ { "rel": "canonical", "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000535103" }, { "rel": "canonical", "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000535103" } ], "noticetype": "OJEU - F3 - Contract Award Notice", "awards": [ { "id": "NP47818-1", "title": "Glatiramer Acetate Injection excluding a manufacturer commissioned Home Delivery Service", "relatedLots": [ "2" ] }, { "id": "NP47818-2", "title": "Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service.", "relatedLots": [ "1" ] } ], "contracts": [ { "id": "NP47818-1", "awardID": "NP47818-1", "title": "Glatiramer Acetate Injection excluding a manufacturer commissioned Home Delivery Service", "status": "active", "dateSigned": "2018-05-01T00:00:00Z" }, { "id": "NP47818-2", "awardID": "NP47818-2", "title": "Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service.", "status": "active", "dateSigned": "2018-05-01T00:00:00Z" } ], "relatedProcesses": [ { "id": "1", "relationship": [ "planning" ], "scheme": "EU-OJ", "identifier": "2018/S 053-116960" } ] }